Clinical Trials

If you are interested in participating in our research, please click here to take a brief survey.

Current Clinical Research Projects at our Clinic

Eisai (Clarity AD)
Protocol: BAN2401-G000-301
Patients: 50-90 years old
Diagnostic: MCI due to AD/Mild AD
Agent: Monoclonal anti-amyloid antibody
Infusion
Currently Enrolling: Yes

Clarity AD Website

vTv Therapeutics LLC (elevage)
Protocol: TTP488-305
Patients: 50-85 years old
Diagnostic: Probable AD
Agent: Azeliragon
Daily Oral Administration
Currently Enrolling: Yes 

elevage Website

TauRx Therapeutics Ltd. (LUCIDITY) 

Protocol: TRx-237-039

Patients: <90 years old

Diagnostic: MCI/Early Alzheimer’s disease

Agent: Leuco-methylthioninium bis(hydromethanesulfonate) (LMTM)

Daily Oral Administration

Currently Enrolling: Yes

Lucidity Website

Athira Pharma Inc. (Act AD) 

Protocol: ATH-1017-AD-0202

Patients: 55-85 years old

Diagnostic: Probable Mild-Moderate AD

Agent: ATH-1017

Daily Subcutaneous Injection

Currently Enrolling: Yes

Act AD Website